Evoked potentials in mitochondrial disorders.

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Mitochondrial diseases are a group of inherited metabolic disorders.
• Central nervous system (CNS) involvement is common but variable in mitochondrial diseases.
• Multimodal evoked potentials (EPs) are non-invasive electrophysiological tests to assess CNS function.

Purpose of the Study:

• To evaluate the utility of multimodal evoked potentials (EPs) in detecting and characterizing central nervous system (CNS) involvement in adult patients with mitochondrial disease.
• To correlate the degree of EP abnormalities with specific clinical phenotypes of mitochondrial disease.

Main Methods:

• Twenty-eight adult patients with confirmed mitochondrial disease were enrolled.
• Patients were categorized into five groups: encephalopathy, progressive external ophthalmoplegia (PEO), pure myopathy, cardiomyopathy, and asymptomatic relatives.
• Multimodal evoked potentials (EPs), including visual, brainstem auditory, and somatosensory EPs, were recorded for all participants.

Main Results:

• Significant differences in EP abnormalities were observed across patient groups.
• The encephalopathy group exhibited widespread EP alterations across all modalities.
• Patients with PEO showed at least one abnormal EP modality, while pure myopathy and cardiomyopathy groups displayed lesser degrees of affection. Asymptomatic relatives had normal EPs.

Conclusions:

• Multimodal evoked potentials (EPs) are sensitive indicators of progressive central nervous system (CNS) damage in mitochondrial diseases.
• A severity spectrum of CNS involvement, detectable by EPs, ranges from encephalopathy and PEO to pure myopathy/cardiomyopathy and asymptomatic states.
• EPs can aid in the clinical classification and monitoring of CNS involvement in mitochondrial disorders.